Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation
Primary Purpose
Spinal Cord Injury
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ReWalk Rehabilitation 2.0
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Cord Injury focused on measuring spinal cord injury, exoskeleton, ambulation, walking, robotics
Eligibility Criteria
Inclusion Criteria:
- SCI level C6-8, T1-T12; L1-L5 incomplete or complete
- Be able to physically fit into the exoskeleton device;
- Be able to tolerate upright standing for a minimum of 30 minutes;
- Have sufficient upper body strength to use forearm crutches in standing and during ambulation (including full triceps strength and good hand function);
- Have hip, knee, and ankle range of motion within normal functional limits of walking;
- Have the ability to follow directions and demonstrate learning capacity;
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- Cervical level SCI above C6
- History of severe osteoporosis;
- Weight above 220 pounds;
- Femur length above 47 cm or below 36 cm
- Joint contractures at the hip, knee, or ankle that limit normal range of motion (ROM) during ambulation;
- Cognitive and/or communication disability (e.g. due to brain injury);
- History of significant problems with skin break down or current skin break down;
- Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity);
- Pregnancy;
- Cardiovascular conditions such as history of heart attack, high blood pressure, pacemaker, arrhythmia, heart failure, or stroke.
Sites / Locations
- Rehabilitation Institute of Chicago
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ReWalk training
Arm Description
Outcomes
Primary Outcome Measures
Change in 6 Minute Walk Test from baseline in distance, RPE and oxygen uptake
The goal is to cover as much ground as possible over 6 minutes, the distance is measured with a measuring wheel. The instructions are "Walk continuously if possible, but do not be concerned if you need to slow down or stop to rest." At the end of 6 minutes the participant is asked to rate their exertion level on a Borg Scale of 6 - 20 points. The VO2 MAX data is collected during the test every 10 seconds
Change in 10 meter walk test from baseline in gait speed
Measure the time in second for and individual to walk 10 meters. The test is Performed using a "flying start," patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: " Please walk this distance as fast as you safely can when I say go."
Time and assistive level to negotiate stairs, ramps, curbs, and turning.
Distance able to reach while standing and sitting
Secondary Outcome Measures
Patient perception of Quality of Life
The Patient Health Questionnaire
PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult).
The Psychosocial Impact of Assistive Devices Scale
The PIADS is a 26-item, self-report questionnaire designed to assess the effects of an assistive device on functional independence, well-being, and quality of life. The PIADS can be used to assess the impact of any assistive device (AD), prosthesis or medical procedure. It can be used to evaluate the impact of ADs over time and to match the devices with consumers. With its excellent psychometric properties, the PIADS fills a missing link in the assessment of ADs as well as in the examination of their acceptance and abandonment.
Activities-specific Balance Confidence Scale
Self reported Spinal Cord Independence Measure in activities of daily living
Pain measure by the Visual Analogue Scale
Full Information
NCT ID
NCT02104622
First Posted
February 26, 2014
Last Updated
May 20, 2020
Sponsor
Shirley Ryan AbilityLab
Collaborators
U.S. Department of Education
1. Study Identification
Unique Protocol Identification Number
NCT02104622
Brief Title
Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation
Official Title
Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation
Study Type
Interventional
2. Study Status
Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
February 2014 (undefined)
Primary Completion Date
January 2020 (Actual)
Study Completion Date
January 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shirley Ryan AbilityLab
Collaborators
U.S. Department of Education
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Many people with spinal cord injury are no longer able to walk and must use wheelchairs for mobility. These individuals experience greater rates of depression and lower quality of life. Many of these individuals express a strong desire to walk again, and report many psychosocial benefits to being eye to eye with peers in social interactions. Additionally, wheelchairs allow only limited community access, creating an additional obstacle to seeking out meaningful social roles in the community. Currently, there is new technology called robotic exoskeletons that would allow people with spinal cord injury to walk. These robotic exoskeletons also allow for curb, ramp, and stair negotiation, which are critical to community access. Current research has examined training with robotic exoskeletons indoors over level surfaces in clinical settings. This study will examine the potential for everyday use, including ramps, stairs, curbs and indoor and outdoor use.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injury
Keywords
spinal cord injury, exoskeleton, ambulation, walking, robotics
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ReWalk training
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
ReWalk Rehabilitation 2.0
Primary Outcome Measure Information:
Title
Change in 6 Minute Walk Test from baseline in distance, RPE and oxygen uptake
Description
The goal is to cover as much ground as possible over 6 minutes, the distance is measured with a measuring wheel. The instructions are "Walk continuously if possible, but do not be concerned if you need to slow down or stop to rest." At the end of 6 minutes the participant is asked to rate their exertion level on a Borg Scale of 6 - 20 points. The VO2 MAX data is collected during the test every 10 seconds
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Change in 10 meter walk test from baseline in gait speed
Description
Measure the time in second for and individual to walk 10 meters. The test is Performed using a "flying start," patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: " Please walk this distance as fast as you safely can when I say go."
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Time and assistive level to negotiate stairs, ramps, curbs, and turning.
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Distance able to reach while standing and sitting
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Secondary Outcome Measure Information:
Title
Patient perception of Quality of Life
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
The Patient Health Questionnaire
Description
PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult).
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
The Psychosocial Impact of Assistive Devices Scale
Description
The PIADS is a 26-item, self-report questionnaire designed to assess the effects of an assistive device on functional independence, well-being, and quality of life. The PIADS can be used to assess the impact of any assistive device (AD), prosthesis or medical procedure. It can be used to evaluate the impact of ADs over time and to match the devices with consumers. With its excellent psychometric properties, the PIADS fills a missing link in the assessment of ADs as well as in the examination of their acceptance and abandonment.
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Activities-specific Balance Confidence Scale
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Self reported Spinal Cord Independence Measure in activities of daily living
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
Title
Pain measure by the Visual Analogue Scale
Time Frame
Session 1 (pre test, initial visit) and Session 20 (post test, between 6-8 weeks)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
SCI level C6-8, T1-T12; L1-L5 incomplete or complete
Be able to physically fit into the exoskeleton device;
Be able to tolerate upright standing for a minimum of 30 minutes;
Have sufficient upper body strength to use forearm crutches in standing and during ambulation (including full triceps strength and good hand function);
Have hip, knee, and ankle range of motion within normal functional limits of walking;
Have the ability to follow directions and demonstrate learning capacity;
Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
Cervical level SCI above C6
History of severe osteoporosis;
Weight above 220 pounds;
Femur length above 47 cm or below 36 cm
Joint contractures at the hip, knee, or ankle that limit normal range of motion (ROM) during ambulation;
Cognitive and/or communication disability (e.g. due to brain injury);
History of significant problems with skin break down or current skin break down;
Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity);
Pregnancy;
Cardiovascular conditions such as history of heart attack, high blood pressure, pacemaker, arrhythmia, heart failure, or stroke.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arun Jayaraman, PT, PhD
Organizational Affiliation
Shirley Ryan AbilityLab
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rehabilitation Institute of Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation
We'll reach out to this number within 24 hrs